Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
About Immunoglobulin Products
Immunoglobulins, also known as antibodies, are proteins that help neutralize foreign objects such as bacteria and viruses. They help recognize and bind to particular antigens. Based on the difference in the amino acid sequence in the fragment crystallizable (Fc) region of the antibody heavy chain, they can be categorized into the following isotypes: IgA, IgD, IgE, IgG, and IgM. In 1952, immunoglobulin products were used for the first time to treat immune deficiency. They can be administered by either the intravenous (IV) or subcutaneous (SC) route. Immunoglobulin products given intravenously usually contain IgG. Immunoglobulin products are used to treat primary antibody deficiency, complex immune deficiency disorders, and life threatening infections. Immunoglobulin therapeutic products help prevent infections, improving the quality of life and increasing life expectancy.
Technavio’s analysts forecast the global immunoglobulin products market to grow at a CAGR of 6.84% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global immunoglobulin products market for the period 2015-2020. To calculate the market size, the report considers revenue generated from the sales of immunoglobulin products used to treat various autoimmune and immunodeficiency diseases.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Immunoglobulin Products Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Baxalta
• Biotest Pharmaceuticals Corp.
• CSL Ltd.
• Grifols SA
• Kedrion SpA
• Octapharma
Other prominent vendors
• Abeona Therapeutics
• Admabiologics
• Anthera
• Beijing Tiantan Biological Products (China)
• Bharat Serums and Vaccines (India)
• Bio Products Laboratory
• China Biologic Products (China)
• Emergent Biosolutions
• Gliknik
• Greencross
• Hansamedical
• Hualan Biological Engineering (China)
• Immunomedics
• Innate Pharma
• Integrated Biotherapeutics
• Janssen Pharmaceuticals
• Kamada
• LFB Group (France)
• Mitsubishi Tanabe Pharma
• Momenta Pharma
• Patrys
• Shanghai RAAS Blood Products (China)
• Sichuan Yuanda Shuyang Pharmaceutical (China)
• Sorrento Therapeutics
Market driver
• Growing aging population
• For a full, detailed list, view our report
Market challenge
• High cost of therapy
• For a full, detailed list, view our report
Market trend
• Patient assistance programs
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Immunoglobulins, also known as antibodies, are proteins that help neutralize foreign objects such as bacteria and viruses. They help recognize and bind to particular antigens. Based on the difference in the amino acid sequence in the fragment crystallizable (Fc) region of the antibody heavy chain, they can be categorized into the following isotypes: IgA, IgD, IgE, IgG, and IgM. In 1952, immunoglobulin products were used for the first time to treat immune deficiency. They can be administered by either the intravenous (IV) or subcutaneous (SC) route. Immunoglobulin products given intravenously usually contain IgG. Immunoglobulin products are used to treat primary antibody deficiency, complex immune deficiency disorders, and life threatening infections. Immunoglobulin therapeutic products help prevent infections, improving the quality of life and increasing life expectancy.
Technavio’s analysts forecast the global immunoglobulin products market to grow at a CAGR of 6.84% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global immunoglobulin products market for the period 2015-2020. To calculate the market size, the report considers revenue generated from the sales of immunoglobulin products used to treat various autoimmune and immunodeficiency diseases.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Immunoglobulin Products Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Baxalta
• Biotest Pharmaceuticals Corp.
• CSL Ltd.
• Grifols SA
• Kedrion SpA
• Octapharma
Other prominent vendors
• Abeona Therapeutics
• Admabiologics
• Anthera
• Beijing Tiantan Biological Products (China)
• Bharat Serums and Vaccines (India)
• Bio Products Laboratory
• China Biologic Products (China)
• Emergent Biosolutions
• Gliknik
• Greencross
• Hansamedical
• Hualan Biological Engineering (China)
• Immunomedics
• Innate Pharma
• Integrated Biotherapeutics
• Janssen Pharmaceuticals
• Kamada
• LFB Group (France)
• Mitsubishi Tanabe Pharma
• Momenta Pharma
• Patrys
• Shanghai RAAS Blood Products (China)
• Sichuan Yuanda Shuyang Pharmaceutical (China)
• Sorrento Therapeutics
Market driver
• Growing aging population
• For a full, detailed list, view our report
Market challenge
• High cost of therapy
• For a full, detailed list, view our report
Market trend
• Patient assistance programs
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
